Abstract:This study presents a comprehensive study exploring the anti‐inflammatory effects of kaempferol (KPR) on human gallbladder epithelial cells (HGBECs) induced by lipopolysaccharide (LPS) and the results indicate that KPR effectively enhances cell viability and reduces inflammatory response markers in LPS‐induced HGBECs possibly by inhibiting the MAPK/NF‐κB signaling pathway. This study contributes valuable insights into the anti‐inflammatory properties of KPR, offering a basis for future therapeutic applications in cholecystitis management. Kaempferol (KPR), a flavonoid compound found in various plants and foods, has garnered attention for its anti‐inflammatory, antioxidant, and anticancer properties. In preliminary studies, KPR can modulate several signaling pathways involved in inflammation, making it a candidate for treating cholecystitis. This study aimed to explore the effects and mechanisms of KPR on lipopolysaccharide (LPS)‐induced human gallbladder epithelial cells (HGBECs). To assess the impact of KPR on HGBECs, the HGBECs were divided into control, KPR, LPS, LPS + KPR, and LPS + UDCA groups. Cell viability and cytotoxicity were evaluated by MTT assay and lactate dehydrogenase (LDH) assay, respectively, and concentrations of KPR (10–200 μM) were tested. LPS‐induced inflammatory responses in HGBECs were to create an in vitro model of cholecystitis. The key inflammatory markers (IL‐1β, IL‐6, and TNF‐α) levels were quantified using ELISA, The modulation of the MAPK/NF‐κB signaling pathway was measured by western blot using specific antibodies against pathway components (p‐IκBα, IκBα, p‐p65, p65, p‐JNK, JNK, p‐ERK, ERK, p‐p38, and p38). The cell viability and LDH levels in HGBECs were not significantly affected by 50 μM KPR, thus it was selected as the optimal KPR intervention concentration. KPR increased the viability of LPS‐induced HGBECs. Additionally, KPR inhibited the inflammatory factors level (IL‐1β, IL‐6, and TNF‐α) and protein expression (iNOS and COX‐2) in LPS‐induced HGBECs. Furthermore, KPR reversed LPS‐induced elevation of p‐IκBα/IκBα, p‐p65/p65, p‐JNK/JNK, p‐ERK/ERK, and p‐p38/p38 ratios. KPR attenuates the LPS‐induced inflammatory response in HGBECs, possibly by inhibiting MAPK/NF‐κB signaling.

Kaempferol inhibited bovine herpesvirus 1 replication and LPS-induced inflammatory response

Kaempferol-3-O-glucorhamnoside Inhibits Inflammatory Responses Via MAPK and NF-κB Pathways in Vitro and in Vivo.

Kaempferol Inhibits Pseudorabies Virus Replication in Vitro Through Regulation of MAPKs and NF-κB Signaling Pathways

Kaempferol Prevents Angiogenesis of Rat Intestinal Microvascular Endothelial Cells Induced by LPS and TNF-α Via Inhibiting VEGF/Akt/p38 Signaling Pathways and Maintaining Gut-Vascular Barrier Integrity.

Kaempferol Inhibits Multiple Pathways Involved in the Secretion of Inflammatory Mediators from LPS‑induced Rat Intestinal Microvascular Endothelial Cells.

Protective Effects of Kaempferol on Lipopolysaccharide-Induced Mastitis in Mice

Kaempferol: A Review of Current Evidence of Its Antiviral Potential

Apigenin And Kaempferol Inhibit Lps-Induced Inflammatory Responses By Regulating Intracellular Translocation Of Rna-Binding Protein Hur In Macrophages

Kaempferol alleviates LPS-ATP mediated inflammatory injury in splenic lymphocytes via regulation of the pyroptosis pathway in mice.

Kaempferol is a novel antiviral agent against channel catfish virus infection through blocking viral attachment and penetration in vitro

The antiviral activity of kaempferol against pseudorabies virus in mice

Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.

Kaempferol exerts anti-inflammatory effects by accelerating Treg development via AhR-mediated and PU.1/IRF4-dependent transactivation of the RALDH2 gene in dendritic cells

Kaempferol inhibits the expression of α-hemolysin and protects mice from methicillin-resistant Staphylococcus aureus-induced lethal pneumonia

Protective Effect of Kaempferol on LPS Plus ATP-Induced Inflammatory Response in Cardiac Fibroblasts

Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF-kappa B signaling pathway

Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice

Kaempferol inhibits the proliferation and migration of Epstein-Barr virus-positive diffuse large B-cell lymphoma cells

Ethyl Acetate Fraction of Flavonoids from Polygonum Hydropiper L. Modulates Pseudorabies Virus-Induced Inflammation in RAW264.7 Cells Via the Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Pathways.

Kaempferol Promotes Apoptosis While Inhibiting Cell Proliferation via Androgen-Dependent Pathway and Suppressing Vasculogenic Mimicry and Invasion in Prostate Cancer

Kaempferol attenuates inflammation in lipopolysaccharide‐induced gallbladder epithelial cells by inhibiting the MAPK/NF‐κB signaling pathway